178 related articles for article (PubMed ID: 24089895)
1. Calculation of dose distributions for 12 106Ru/106Rh ophthalmic applicator models with the PENELOPE Monte Carlo code.
Hermida-López M
Med Phys; 2013 Oct; 40(10):101705. PubMed ID: 24089895
[TBL] [Abstract][Full Text] [Related]
2. Calculation of beta-ray dose distributions from ophthalmic applicators and comparison with measurements in a model eye.
Cross WG; Hokkanen J; Järvinen H; Mourtada F; Sipilä P; Soares CG; Vynckier S
Med Phys; 2001 Jul; 28(7):1385-96. PubMed ID: 11488569
[TBL] [Abstract][Full Text] [Related]
3. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
Mostafa L; Rachid K; Ahmed SM
Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
[TBL] [Abstract][Full Text] [Related]
4. Absorbed dose distributions from ophthalmic
Hermida-López M; Brualla L
Med Phys; 2018 Apr; 45(4):1699-1707. PubMed ID: 29399810
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.
Sánchez-Reyes A; Tello JI; Guix B; Salvat F
Radiother Oncol; 1998 Nov; 49(2):191-6. PubMed ID: 10052886
[TBL] [Abstract][Full Text] [Related]
6. A patch source model for treatment planning of ruthenium ophthalmic applicators.
Astrahan MA
Med Phys; 2003 Jun; 30(6):1219-28. PubMed ID: 12852546
[TBL] [Abstract][Full Text] [Related]
7. [Therapy relevant weak sites in industrial quality assurance of 106Ru eye plaques].
Kaulich TW; Zurheide J; Flühs D; Haug T; Nüsslin F; Bamberg M
Strahlenther Onkol; 2001 Nov; 177(11):616-23; discussion 624-7. PubMed ID: 11757185
[TBL] [Abstract][Full Text] [Related]
8. A simple calibration method for 106Ru-106Rh eye applicators.
Kovacević N; Vrtar M; Vekić B
Radiother Oncol; 2005 Mar; 74(3):293-9. PubMed ID: 15763310
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional dosimetry of ¹⁰⁶Ru eye plaques using EBT3 films and its impact on treatment planning.
Heilemann G; Nesvacil N; Blaickner M; Kostiukhina N; Georg D
Med Phys; 2015 Oct; 42(10):5798-808. PubMed ID: 26429254
[TBL] [Abstract][Full Text] [Related]
10. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
[TBL] [Abstract][Full Text] [Related]
11. The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators.
Flühs D; Anastassiou G; Wening J; Sauerwein W; Bornfeld N
Med Phys; 2004 Jun; 31(6):1481-8. PubMed ID: 15259651
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
Miras H; Terrón JA; Lallena AM
Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
[TBL] [Abstract][Full Text] [Related]
13. The determination of dose characteristics of ruthenium ophthalmic applicators using radiochromic film.
Taccini G; Cavagnetto F; Coscia G; Garelli S; Pilot A
Med Phys; 1997 Dec; 24(12):2034-7. PubMed ID: 9434987
[TBL] [Abstract][Full Text] [Related]
14. Energy deposition by a 106Ru/106Rh eye applicator simulated using LEPTS, a low-energy particle track simulation.
Fuss MC; Muñoz A; Oller JC; Blanco F; Williart A; Limão-Vieira P; Borge MJ; Tengblad O; Huerga C; Téllez M; García G
Appl Radiat Isot; 2011 Sep; 69(9):1198-204. PubMed ID: 21543231
[TBL] [Abstract][Full Text] [Related]
15. [Dosimetry of ruthenium applicators with an eye phantom and small volume thermoluminescence detectors].
Muskalla K; Pothmann B; Alberti W; Bornfeld N; Foerster MH; Harder D; Hermann KP; Tabor P; Sack H; Wessing A
Fortschr Ophthalmol; 1989; 86(6):655-8. PubMed ID: 2625294
[TBL] [Abstract][Full Text] [Related]
16. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
[TBL] [Abstract][Full Text] [Related]
17. Clinical quality assurance for 106Ru ophthalmic applicators.
Kaulich TW; Zurheide J; Haug T; Nüsslin F; Bamberg M
Radiother Oncol; 2005 Jul; 76(1):86-92. PubMed ID: 15972240
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
[TBL] [Abstract][Full Text] [Related]
19. Calculation of electron and isotopes dose point kernels with FLUKA Monte Carlo code for dosimetry in nuclear medicine therapy.
Botta F; Mairani A; Battistoni G; Cremonesi M; Di Dia A; Fassò A; Ferrari A; Ferrari M; Paganelli G; Pedroli G; Valente M
Med Phys; 2011 Jul; 38(7):3944-54. PubMed ID: 21858991
[TBL] [Abstract][Full Text] [Related]
20. Estimates of relative beta radiation doses on central and lateral axes of ruthenium/rhodium COB-type plaque used in eye brachytherapy.
De Paiva E
Appl Radiat Isot; 2020 Feb; 156():108991. PubMed ID: 32056686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
